Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.0K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

748
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
748

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving Hepatocellular Carcinoma Surveillance in Ambulatory Hepatology: A PDSA Quality Improvement Initiative.

Nursing reports (Pavia, Italy)·2026
Same author

Management of a Kratom and Tianeptine Overdose.

Journal of pharmacy practice·2026
Same author

Restriction Evaluation of Appropriate Carbapenem Therapy (REACT): A Multisite Observational Study.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2026
Same author

Cancer Therapy-Induced Cardiotoxicity: A Narrative Review.

Pharmacotherapy·2026
Same author

Retrospective, Single-Center Evaluation of Dose Tapering Strategies of Dexamethasone in Hospitalized Patients With Malignant Spinal Cord Compression.

Journal of pharmacy practice·2026
Same author

Delayed presentation of pembrolizumab-induced SJS-TEN overlap syndrome.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2025

Related Experiment Video

Updated: Feb 28, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.5K

Probable Tirzepatide-Induced Rhabdomyolysis in an HIV-Positive Patient.

Drew A Wells1,2, Kaulin Duncan3, Sami Sakaan1,2

  • 1Methodist Le Bonheur Healthcare - University Hospital, Memphis, TN, USA.

Hospital Pharmacy
|February 27, 2026
PubMed
Summary

Tirzepatide, used for diabetes and weight loss, may cause rhabdomyolysis, a serious muscle condition. This case highlights a potential risk in human immunodeficiency virus (HIV)-positive patients, emphasizing the need for vigilance.

Area of Science:

  • Pharmacology
  • Endocrinology
  • Infectious Diseases

Background:

  • Tirzepatide is a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist.
Keywords:
adverse drug reactionsdrug informationendocrinemetabolic

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.5K
Cellular Redox Profiling Using High-content Microscopy
11:37

Cellular Redox Profiling Using High-content Microscopy

Published on: May 14, 2017

11.6K

Related Experiment Videos

Last Updated: Feb 28, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.5K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.5K
Cellular Redox Profiling Using High-content Microscopy
11:37

Cellular Redox Profiling Using High-content Microscopy

Published on: May 14, 2017

11.6K
  • It is widely prescribed for type 2 diabetes, obesity, and obstructive sleep apnea.
  • This report details a probable case of tirzepatide-associated rhabdomyolysis in an HIV-positive individual.